Cargando…
Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
BACKGROUND: Concurrent chemoradiation is the standard treatment for patients with advanced head and neck squamous cell carcinoma (HNSCC). The present study was carried out to assess the feasibility and efficacy of low-dose gemcitabine as a radiosensitizer when used during radical therapeutic managem...
Autores principales: | Ali, Elsayed M, Abdelraheem, Ahmad G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240827/ https://www.ncbi.nlm.nih.gov/pubmed/22085617 http://dx.doi.org/10.1186/1758-3284-3-48 |
Ejemplares similares
-
Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2015) -
Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis
por: Tang, Wen-Hua, et al.
Publicado: (2020) -
Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
por: Abdelhafiz, Nora, et al.
Publicado: (2023) -
Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance
por: Mashhour, Karim, et al.
Publicado: (2020) -
Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
por: Yang, Hua, et al.
Publicado: (2013)